Pediatr Gastroenterol Hepatol Nutr.  2012 Dec;15(4):220-228.

Gastro-Esophageal Reflux Disease in Healthy Older Children and Adolescents

• Park KY
• Chang SH

Abstract

Gastro-esophageal reflux disease (GERD) in otherwise healthy older children and adolescents is commonly encountered in pediatric clinics and poses a complex treatment problem involving changes of diets and lifestyle. After an initial history taking and a physical examination, typical symptoms of GERD in older children and adolescenct are initially treated with the trials of acid suppressants. With an increase of severe cases, more and more GERD children have been evaluated with endoscopy, which helps to delineate an erosive esophagitis from a non-erosive reflux disease as they are presumed to have different pathogenesis. For the pediatric patients without a significant underlying disease, a reflux esophagitis can be treated adequately with acid suppressants. Recently, the rapid increase of children who are taking anti-reflux medication has brought up a serious alarm among pediatricians. Some at risk pediatric patients with recurrent and/or chronic GERD have been linked to adulthood GERD. In this paper, pediatric GERD with and without erosive esophagitis was reviewed along with treatment options and issues specifically for the otherwise healthy older children and adolescents in the primary clinics or the secondary hospitals.

Keyword

Gastroesophageal reflux; Child; Adolescents

MeSH Terms

Adolescent
Child
Diet
Endoscopy
Esophagitis
Esophagitis, Peptic
Gastroesophageal Reflux
Humans
Life Style
Physical Examination

Reference

1. Thakkar K, Dorsey F, Gilger MA. Impact of endoscopy on management of chronic abdominal pain in children. Dig Dis Sci. 2011. 56:488–493.

2. Gold BD, Freston JW. Gastro-esophageal reflux in children: pathogenesis, prevalence, diagnosis, and role of proton pump inhibitors in treatment. Paediatr Drugs. 2002. 4:673–685.

3. Nelson SP, Chen EH, Syniar GM, Christoffel KK. Pediatric Practice Research Group. Prevalence of symptoms of Gastro-esophageal reflux during childhood: a pediatric practice-based survey. Arch Pediatr Adolesc Med. 2000. 154:150–154.

4. Lee JH, Kim MJ, Lee JS, Choe YH. The effects of three alternative treatment strategies after 8 weeks of proton pump inhibitor therapy for GERD in children. Arch Dis Child. 2011. 96:9–13.

5. Seo JK, Chi JG, Kim EC. Gastrofibersoscopic findings and Helicobacter-pylori gastritis in children with recurrent abdominal pain. J Korean Pediatr Soc. 1992. 35:1646–1656.

6. Kwon HJ, Yi DY, Ryoo E, Cho KH, Son DW, Tcha H. Prevalence and risk factors associated with esophagitis in children with abdominal pain. Korean J Pediatr Gastroenterol Nutr. 2008. 11:103–109.

7. Vandenplas Y, Rudolph CD, Di Lorenzo C, Hassall E, Liptak G, Mazur L, et al. Pediatric Gastro-esophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr. 2009. 49:498–547.

8. Sherman PM, Hassall E, Fagundes-Neto U, Gold BD, Kato S, Koletzko S, et al. A global, evidence-based consensus on the definition of Gastro-esophageal reflux disease in the pediatric population. Am J Gastroenterol. 2009. 104:1278–1295.

9. Gupta SK, Hassall E, Chiu YL, Amer F, Heyman MB. Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients. Dig Dis Sci. 2006. 51:858–863.

10. Boccia G, Manguso F, Miele E, Buonavolontà R, Staiano A. Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable? Am J Gastroenterol. 2007. 102:1291–1297.

11. Gilger MA, El-Serag HB, Gold BD, Dietrich CL, Tsou V, McDuffie A, et al. Prevalence of endoscopic findings of erosive esophagitis in children: a population-based study. J Pediatr Gastroenterol Nutr. 2008. 47:141–146.

12. Loots CM, Benninga MA, Omari TI. Gastro-esophageal reflux in pediatrics; (patho)physiology and new insights in diagnostics and treatment. Minerva Pediatr. 2012. 64:101–119.

13. Tolia V, Essenbacher L, Boyer K, Ager J. Incidence of infantile and familial Ger in children with Gastroesophageal reflux disease (Gerd). J Pediatr Gastroenterol Nutr. 2004. 39:S427.

14. Uzun H, Alagoz D, Okur M, Dikici B, Kocabay K, Senses DA, et al. Do gastrointestinal and respiratory signs and symptoms correlate with the severity of Gastro-esophageal reflux? BMC Gastroenterol. 2012. 12:22–26.

15. Ruigómez A, Wallander MA, Lundborg P, Johansson S, Rodriguez LA. Gastro-esophageal reflux disease in children and adolescents in primary care. Scand J Gastroenterol. 2010. 45:139–146.

16. Canani RB, Cirillo P, Roggero P, Romano C, Malamisura B, Terrin G, et al. Working Group on Intestinal Infections of the Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition (SIGENP). Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics. 2006. 117:e817–e820.

17. Hwang JK, Kim J, Hong SG, Jung SJ, Joo MK, Lee BJ, et al. A prospective multicenter study on the prevalence and symptoms of erosive reflux esophagitis in secondary and tertiary hospitals in Korea. Korean J Gastroenterol. 2009. 53:283–291.

18. Jiang M, Chen J, Chen F, Yu J, Liang J, Zhang Y, et al. Bile and acid reflux in the pathogenesis of reflux oesophagitis in children. J Paediatr Child Health. 2009. 45:64–67.

19. Winter HS, Illueca M, Henderson C, Vaezi M. Review of the persistence of Gastro-esophageal reflux disease in children, adolescents and adults: does gastroesophageal reflux disease in adults sometimes begin in childhood? Scand J Gastroenterol. 2011. 46:1157–1168.

20. Sifrim D, Holloway R, Silny J, Xin Z, Tack J, Lerut A, et al. Acid, nonacid, and gas reflux in patients with Gastro-esophageal reflux disease during ambulatory 24-hour pH-impedance recordings. Gastroenterology. 2001. 120:1588–1598.

21. Beaumont H, Bennink RJ, de Jong J, Boeckxstaens GE. The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD. Gut. 2010. 59:441–451.

22. Orel R, Markovic S. Bile in the esophagus: a factor in the pathogenesis of reflux esophagitis in children. J Pediatr Gastroenterol Nutr. 2003. 36:266–273.

23. Lee SH, Jang JY, Yoon IJ, Kim KM. Usefulness of multichannel intraluminal impedance-pH metry in children with suspected Gastro-esophageal reflux disease. Korean J Gastroenterol. 2008. 52:9–15.

24. Emerenziani S, Sifrim D. Gastro-esophageal reflux and gastric emptying, revisited. Curr Gastroenterol Rep. 2005. 7:190–195.

25. Tolia V, Youssef NN, Gilger MA, Traxler B, Illueca M. Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study. BMC Pediatr. 2010. 10:41–50.

26. Kaijser M, Akre O, Cnattingius S, Ekbom A. Preterm birth, low birth weight, and risk for esophageal adenocarcinoma. Gastroenterology. 2005. 128:607–609.

27. Hancox RJ, Poulton R, Taylor DR, Greene JM, McLachlan CR, Cowan JO, et al. Associations between respiratory symptoms, lung function and gastro-oesophageal reflux symptoms in a population-based birth cohort. Respir Res. 2006. 7:142–151.

28. Hassall E. Decisions in diagnosing and managing chronic Gastro-esophageal reflux disease in children. J Pediatr. 2005. 146:3 Suppl. S3–S12.

29. Ruigómez A, Hungin AP, Lundborg P, Johansson S, Wallander MA, García Rodríguez LA. Treatment patterns in paediatric patients with a new diagnosis of Gastro-esophageal reflux disease. Eur J Gastroenterol Hepatol. 2011. 23:232–237.

30. Smoak BR, Koufman JA. Effects of gum chewing on pharyngeal and esophageal pH. Ann Otol Rhinol Laryngol. 2001. 110:1117–1119.

31. Merki HS, Halter F, Wilder-Smith CH. Diurnal secretory patterns and tolerance during individually titrated infusions of ranitidine. Gastroenterology. 1993. 105:748–754.

32. Tofil NM, Benner KW, Fuller MP, Winkler MK. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH. J Crit Care. 2008. 23:416–421.

33. Litalien C, Théorêt Y, Faure C. Pharmacokinetics of proton pump inhibitors in children. Clin Pharmacokinet. 2005. 44:441–466.

34. Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr. 2007. 150:262–267. 267.e1

35. Romano C, Chiaro A, Comito D, Loddo I, Ferrau V. Proton pump inhibitors in pediatrics: evaluation of efficacy in GERD therapy. Curr Clin Pharmacol. 2011. 6:41–47.

36. Pettersen G, Mouksassi MS, Théorêt Y, Labbé L, Faure C, Nguyen B, et al. Population pharmacokinetics of intravenous pantoprazole in paediatric intensive care patients. Br J Clin Pharmacol. 2009. 67:216–227.

37. Katz PO, Ginsberg GG, Hoyle PE, Sostek MB, Monyak JT, Silberg DG. Relationship between intragastric acid control and healing status in the treatment of moderate to severe erosive oesophagitis. Aliment Pharmacol Ther. 2007. 25:617–628.

38. Savarino V, Di Mario F, Scarpignato C. Proton pump inhibitors in GORD An overview of their pharmacology, efficacy and safety. Pharmacol Res. 2009. 59:135–153.

39. Monzani A, Oderda G. Delayed-release oral suspension of omeprazole for the treatment of erosive esophagitis and Gastro-esophageal reflux disease in pediatric patients: a review. Clin Exp Gastroenterol. 2010. 3:17–25.

40. Fiedorek S, Tolia V, Gold BD, Huang B, Stolle J, Lee C, et al. Efficacy and safety of lansoprazole in adolescents with symptomatic erosive and non-erosive Gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr. 2005. 40:319–327.

41. Guillet R, Stoll BJ, Cotten CM, Gantz M, McDonald S, Poole WK, et al. National Institute of Child Health and Human Development Neonatal Research Network. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2006. 117:e137–e142.

42. Ngamruengphong S, Leontiadis GI, Radhi S, Dentino A, Nugent K. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies. Am J Gastroenterol. 2011. 106:1209–1218.

43. El-Serag HB, Gilger M, Carter J, Genta RM, Rabeneck L. Childhood GERD is a risk factor for GERD in adolescents and young adults. Am J Gastroenterol. 2004. 99:806–812.

44. Orenstein SR. Pediatric erosive esophagitis maintenance: finally, some level 1 evidence! Am J Gastroenterol. 2007. 102:1298–1300.

45. Mousa HM, Rosen R, Woodley FW, Orsi M, Armas D, Faure C, et al. Esophageal impedance monitoring for Gastro-esophageal reflux. J Pediatr Gastroenterol Nutr. 2011. 52:129–139.

46. Rosen R, Nurko S. The importance of multichannel intraluminal impedance in the evaluation of children with persistent respiratory symptoms. Am J Gastroenterol. 2004. 99:2452–2458.